- Home
- RSLS vs SANW Comparison
RSLS vs SANW Comparison
Compare RSLS & SANW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RSLS
- SANW
- Stock Information
- Founded
- RSLS 2002
- SANW 1980
- Country
- RSLS United States
- SANW United States
- Employees
- RSLS N/A
- SANW N/A
- Industry
- RSLS Medical/Dental Instruments
- SANW Farming/Seeds/Milling
- Sector
- RSLS Health Care
- SANW Consumer Staples
- Exchange
- RSLS Nasdaq
- SANW Nasdaq
- Market Cap
- RSLS 5.7M
- SANW 4.6M
- IPO Year
- RSLS 2007
- SANW 2010
- Fundamental
- Price
- RSLS $2.58
- SANW $0.32
- Analyst Decision
- RSLS
- SANW Strong Buy
- Analyst Count
- RSLS 0
- SANW 1
- Target Price
- RSLS N/A
- SANW $25.00
- AVG Volume (30 Days)
- RSLS 458.6K
- SANW 109.2K
- Earning Date
- RSLS 08-18-2025
- SANW 05-15-2025
- Dividend Yield
- RSLS N/A
- SANW N/A
- EPS Growth
- RSLS N/A
- SANW N/A
- EPS
- RSLS N/A
- SANW N/A
- Revenue
- RSLS $7,175,000.00
- SANW $54,993,808.00
- Revenue This Year
- RSLS $52.80
- SANW N/A
- Revenue Next Year
- RSLS N/A
- SANW $17.19
- P/E Ratio
- RSLS N/A
- SANW N/A
- Revenue Growth
- RSLS N/A
- SANW 6.91
- 52 Week Low
- RSLS $2.23
- SANW $0.38
- 52 Week High
- RSLS $303.25
- SANW $11.60
- Technical
- Relative Strength Index (RSI)
- RSLS 45.22
- SANW 17.18
- Support Level
- RSLS $2.35
- SANW $0.20
- Resistance Level
- RSLS $2.56
- SANW $2.15
- Average True Range (ATR)
- RSLS 0.25
- SANW 0.25
- MACD
- RSLS 0.05
- SANW -0.06
- Stochastic Oscillator
- RSLS 21.77
- SANW 5.91
About RSLS ReShape Lifesciences Inc.
Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus. Geographically, the company operates in the United States, Australia, Europe, and the Rest of world, and the majority of its revenue is generated from the United States.
About SANW S&W Seed Company (NV)
S&W Seed Co is a multi-crop, middle-market agricultural company. It is engaged in the breeding, production, and sale of alfalfa seed and sorghum seed. It also has a growing commercial market presence in sunflower and maintains an active stevia development program. The company's seed platform develops and supplies germplasm designed to produce higher yields for farmers globally. Its geographical segments include the United States, Australia, Saudi Arabia, Mexico, South Africa, and other countries. Maximum of revenue is earned from USA following Australia second and Mexico third.